Submission of Statement of Deviation & Variation

#nffi^*w,wn Date: l3rh August, 2026 The Deputy Manager Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai-400001. sub: Statement of Deviation andvariation as per crause 32 (l), (2) and (3) for the quarter ended 30th June, 2026 under the SEBI (Listing obrigation and Discrosure Requirements), 2015. Ref: Scrip Code: 536565 Scrip Id: NOVELIX Dear Sir/Madam, Please find enclosed herewith Statement of Deviation and Variation as per Clause 32( l ) for the quarter ended 30th June, 2026 under the SEBI (Listing obrigation and dir"lo.u." Requirements), 2015. The said statement was reviewed by Audit committee and Board meeting held on l3th August, 2026. Kindly acknowledge the same. Thanking you Yours sincerely, For Novelix Venkateshwarlu Pulluru (Whole-time director) DIN: 02076871 Novelix pharmaceuticals limited (Formerty Known as TRt URTH| TTED) H No: l-6'217/6ro, Flat No:61o,6rh Froor, Lingapur LA Builders, Arso Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 ph No: +91 99776j1o44 Emailt novelixpharmaceuticals@gmail.com www.novelixpharma.com #nffi,^{ffi,w* STA (T PE uM rsE uN anT t O toF R D eI gV uIA taT tiI oO nN 3 2O (l)R ,, V (2A ) R a] nA dT (I 3O )N o f IN S EU BT iI L OIS OA OT nIO I N n "O gF r fF "U tiN ",D S iO R iA l]I ,S "E "D " Name of listed entity Novelix Pha.muceuticals limited 6ormefi Trimurthi Limited) Mode of Fund Raising Date of Raising Fundi Monitoring Agency Namejl applicable /t*i"ti", Is there a Deviation i, ,re yes, whether th" rurrr" i" pursuant to change in terms of a contract or objects, which was If Yes, Date of shareholder for the Deviation f Variation Comments of the Audit Com-itt"e aft". No Comments Comments of the auditors. if Objects for which funds have been ,uis"d where there has been a deviation. in the following table 0riginal Modifie Original Modified Funds Amount of Object d Allocation allocation Utilized (Rs. Deviation/Vari Object, (Rs. In ,if In Lakhs) ation Lakhs) any for the quarter according to applicable To the object 421.50t- 42t.50t- of meeting the long term funding requirements ofthe Company including but not limited to working capital requirements and for general corporate Novelix Pharmaceuticals limited (Formorty Known as TRtt URTHI LtMtTED) H No: 3-6-237/6io, Flat No: 610, 6Th Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Telangana- 5ooo29 Ph No; +91 8977631o44 Emait: novelixph.rmaceuti€als@gmait.com www,novelixpharma.com order to support the future growth plan of the Company. Deviation or variation could mean: (a) Deviation in the objects or p,lposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilizeJ * *t" *". disclosed or "g"iru ".iiirally (c) Change in terms ofa contract referred to in the fund_raising docunrent. For Novelix i"t.tr} Venkateshwarlu (Whole-time director) DIN: 02076871 Novelix pharmaceuticats limited (Formerly Known as TRIITURTHI LtiilTED) H No: 3-6-237/610, Flat No: 61o, 6rh Floor, Lingapur LA Builders, Also Known as Amrutha Estates, Himayat Nagar, Hyderabad, Terangana- 50002g ph No: +gl 8977611044 Email: noverixpharmaceuticars@gmair.com www.novelixpharma.com